Steris (STE) Loses 6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Steris (STE) stock, which has experienced a 6% decline over the past four weeks, is now signaling a potential trend reversal. This outlook is supported by its Relative Strength Index (RSI) of 27.46, indicating oversold conditions, alongside a recent 0.1% increase in consensus earnings per share estimates for the current year by sell-side analysts. Furthermore, the stock holds a Zacks Rank #2 (Buy), collectively suggesting a near-term rebound.

Analysis

Steris (STE) has experienced significant selling pressure, resulting in a 6% price decline over the last four weeks. However, a combination of technical and fundamental signals suggests a potential near-term trend reversal. From a technical perspective, the stock's Relative Strength Index (RSI) has reached 27.46, falling below the 30 threshold that typically indicates an oversold condition. This suggests the recent downward momentum may be exhausted. This technical signal is reinforced by a positive fundamental development: a 0.1% increase in the consensus earnings per share (EPS) estimate for the current year over the past 30 days, indicating growing optimism among sell-side analysts. Furthermore, the stock's Zacks Rank #2 (Buy) rating, which is based on earnings estimate revisions and surprises, provides a quantitative layer of support for a potential rebound.

Key Decisions for Investors

• Given the oversold RSI reading of 27.46 and the upward revision in EPS estimates, investors could consider this a potential tactical entry point for a near-term rebound.
• It is prudent to watch for confirmation signals, such as the RSI moving back above 30, as technical indicators can provide false positives and should not be used in isolation.
• Monitor for continued positive momentum in analyst earnings revisions, as the current 0.1% increase is modest and a sustained upward trend would provide a stronger fundamental basis for a price recovery.